Key result
PCI for SIHD fails to reduce long-term mortality or MI compared to OMT.
Why the study?
Does percutaneous coronary intervention reduce death or myocardial infarction in patients with stable ischemic heart disease?
Does percutaneous coronary intervention reduce death or myocardial infarction in patients with stable ischemic heart disease?
Current evidence supports optimal medical therapy as a safe, effective, and noninferior first-line strategy compared to PCI for patients with stable ischemic heart disease.
No takes yet. Share an insight, caveat, or question.
Supports optimal medical therapy as first-line for stable ischemic heart disease; confirms trial data but leaves open questions for contemporary stents and subgroups.
Weintraub et al. (2016) conducted a review in Stable ischemic heart disease. Percutaneous coronary intervention (PCI) vs. Optimal medical therapy was evaluated on Death or myocardial infarction. Percutaneous coronary intervention for stable ischemic heart disease does not reduce long-term mortality (up to 15 years) or myocardial infarction compared to optimal medical therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: